Skip to main content
SpringerLink
Log in

Nutritional and Non-Nutritional Uses of Vitamin B6

  • Chapter
Food and Nutritional Supplements

Abstract

Nutritional deficiency of vitamin B6 is essentially unknown, although a significant proportion of the population in developed countries show biochemical ev dence of inadequate or marginal vitamin B6 nutritional status, despite intakes that meet or exceed reference intakes, suggesting that current estimates of requirements may be too low. Furthermore, since estimates of requirement are based on prevention of deficiency, it is relevant to consider whether somewhat higher intakes may be beneficial in terms of promoting optimum nutrition.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Department of Health. Committee on Toxicity of Chemieals In Pood, Consumer Products and the Environment. Statement on vitamin B6 (pyridoxine) toxicity.http://www.open.gov.uk! doh/hef/B6.htm.1997

    Google Scholar 

  2. Ink SL, Henderson LM. Vitamin B6 metabolism. Annual Review of Nutrition 1984; 4: 455–470

    Article  CAS  Google Scholar 

  3. Bender DA. Oestrogens and vitamin B6 — actions and interactions. World Review of Nutrition and Dietetics 1987; 51: 140–88

    CAS  Google Scholar 

  4. Allgood VE, Cidlowski JA. Vitamin — modulates transcriptional activation by multiple members of the steroid hormone receptor superfamily. Journal of Biological Chemistry 1992;267:3819–3824

    CAS  Google Scholar 

  5. Wiss O, Weber F. Biochemical pathology of vitamin — deficiency. Vitamins and Hormones 1964;22:495–501

    Article  CAS  Google Scholar 

  6. Department of Health. Report on Health and Social Subjects no 41: Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. 1991, London, HMSO

    Google Scholar 

  7. National Research Council. Recommended Dietary Allowances 10th Edition. 1989, Washington, National Academy Press

    Google Scholar 

  8. Bender DA. Vitamin B6 requirements and recommendations. European Journal of Clinical Nutrition 1989; 43: 289–300

    CAS  Google Scholar 

  9. Verhoef P, Stampfer MJ. Prospective studies of homocysteine and cardiovascular disease. Nutrition Reviews 1995; 3: 283–288

    Google Scholar 

  10. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. Journal of the American Medical Association 1993; 270: 2693–2698

    Article  CAS  Google Scholar 

  11. Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE, Hennekens C, Stampfer MJ. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. Journal of the American Medical Association 1998; 279: 359–364

    Article  CAS  Google Scholar 

  12. Dierkes J, Kroesen M, Pietrzik K. Folie acid and vitamin B6 supplementation in healthy young women. International Journal of Vitamin and Nutrition Research 1998; 68: 98–103

    CAS  Google Scholar 

  13. Ubbinck JB, Vermaak WJH, van der Merwe A, Becker PJ, Delport R, Potgieter He. Vitamin requirements for the treatment of hyperhomocystinaemia in humans. Journal of Nutrition 1994; 124: 1927–1933

    Google Scholar 

  14. Ubbinck JB. The role of vitamins in the pathogenesis and treatment of hyperhomocyst(e)inaemia. Journal of Inherited Metabolie Diseases 1997; 20: 316–325

    Article  Google Scholar 

  15. Homocysteine lowering trialists’ collaboration. Lowering blood homocysteine with folie acid based supplements: meta-analysis of randomised trials. British Medical Journal 1998; 316:894–898

    Article  Google Scholar 

  16. Merrill AH, Henderson LM. Diseases associated with defects in vitamin B6 metabolism or utilisation. Annual Review of Nutrition 1987; 7: 137–156

    Article  CAS  Google Scholar 

  17. Bender DA. Non-nutritional uses of vitamin B6. British Journal of Nutrition 1999; 81: 7–20

    CAS  Google Scholar 

  18. Rose DP. The influence of oestrogens on tryptophan metabolism in man. Clinical Science 1966;31:265–272

    CAS  Google Scholar 

  19. Meister A. On the transamination of enzymes. Annals of the New York Academy of Seiences 1990; 585: 13–31

    Article  CAS  Google Scholar 

  20. Bender DA, Wynick D. Inhibition of kynureninase (L-kynurenine hydrolase, EC3.7.1.3) by oestrone sulphate, an alternative explanation for abnormal results of tryptophan load tests in women receiving oestrogenie steroids. British Journal of Nutrition 1981; 45: 269–275

    Article  CAS  Google Scholar 

  21. Wynn V, Doar JW. Some effects of oral contraceptives on carbohydrate metabolism. Lancet 1966; (ii) 715–719

    Article  Google Scholar 

  22. Rose DP, Leklern JE, Brown RR, Linkswiler HM. Effect of oral contraceptives and vitamin B6 deficiency on carbohydrate metabolism. American Journal of Clinical Nutrition 1975; 28:872–878

    CAS  Google Scholar 

  23. Bender DA, Totoe L. Inhibition of tryptophan metabolism by oestrogens in the rat, a factor in the aetiology of pellagra. British Journal of Nutrition 1984; 51: 219–224

    Article  CAS  Google Scholar 

  24. Kotake Y, Ueda T, Mori T, Igaki S, Hattori M. Abnormal tryptophan metabolism and experimental diabetes by xanthurenic acid. Acta Vitaminologica et Enzymologica 1975; 29: 236–239

    CAS  Google Scholar 

  25. Adams PW, Wynn V, Folkard J, Seed M. Influence of oral contraceptives, pyridoxine (vitamin B6), and tryptophan on carbohydrate metabolism. Lancet 1976; (i) 759–764

    Article  Google Scholar 

  26. Rao RH. Glucose tolerance in subclinical pyridoxine deficiency in man. American Journal of Clinical Nutrition 1983; 38: 440–444

    CAS  Google Scholar 

  27. Toyota T, Kai Y, Kakizaki M, Ohtsuka H, Shibata Y, Goto Y. The endocrine pancreas in pyridoxine deficient rats. Tohoku Journal of Experimental Medicine 1981; 134: 331–336

    Article  CAS  Google Scholar 

  28. Rao KS, Mohan PS. Plasma somatomedin activity, growth hormone and insulin levels in vitamin B6 deficient rats. Hormoneand Metabolie Research 1982; 14: 580–582

    Article  CAS  Google Scholar 

  29. Hayakawa M, Shibata M. The in vitro and in vivo inhibition of pro tein glycosylation and diabetic vascular basement membrane thickening by pyridoxal 5′-phosphate. Journal of Nutritional Science and Vitaminology(Tokyo) 1991; 37: 149–159

    Article  CAS  Google Scholar 

  30. Solomon LR, Cohen K. Erythrocyte O2 transport and metabolism and effects of vitamin B6 therapy in type II diabetes mellitus. Diabetes 1989;38: 881–886

    Article  CAS  Google Scholar 

  31. Eiduson S, Yuwiler A, Eberle ED. The effect of pyridoxine deficiency on L-aromatic amino acid decarboxylase and tyrosine aminotransferase in developing rat brain. Advances in Biochemical Psychopharmacology 1972; 4:63–80

    CAS  Google Scholar 

  32. Perry TL, Yong VW, Kish SJ, Ho M, Foulks JG, Godolphin WJ, Sweeney VP. Neurochemical abnormalities in brains of renal failure patients treated by repeated hemodialysis. Journal of Neurochemistry 1985; 45: 1043–1048

    Article  CAS  Google Scholar 

  33. Bender DA, Totoe I. High doses of vitamin B6 are associated with inhibition of hepatic tryptophan metabolism and increased uptake of tryptophan into the brain. Journal of Neurochemistry 1984;43: 733–736

    Article  CAS  Google Scholar 

  34. Ritchie CD, Singkamani R. Plasma pyridoxal 5′-phosphate in women with the premenstrual syndrome. Human Nutrition: Clinical Nutrition 1986;40: 75–80

    CAS  Google Scholar 

  35. van den Berg H, Louwerse ES, Bruinse HW, Thissen JT, Schrijver J. Vitamin B6 status of women suffering from premenstrual syndrome. Human Nutrition: Clinical Nutrition 1986;40:441–450

    Google Scholar 

  36. Mira M, Stewart P M, Abraham SEVitamin and trace element status in premenstrual syndrome. AmericanJournal of Clinical Nutrition 1988;47: 636–641

    CAS  Google Scholar 

  37. Kleijnen J, Ter-Riet G, Knipschild P. Vitamin — in the treatment of the premenstrual syndrome — a review. British Journalof Obstetrics and Gynaecology 1990;97: 847–852

    Article  CAS  Google Scholar 

  38. Hagen I, Nesheim BI, Tuntland T. No effect of vitamin B-6 against premenstrual tension. Acontrolled clinicalstudy. Acta Obstetricaet Gynecologica Scandinavica 1985;64: 667–670

    Article  CAS  Google Scholar 

  39. Brent RL. Bendectin: review of the medicalliterature of a comprehensively studied human nonteratogen and the most prevalent tortogenlitigen. Reproductive Toxicology 1995; 9: 337–349

    Article  CAS  Google Scholar 

  40. Sahakian V, Rouse D, Sipes S, Rose N, Niebyl J. Vitamin — is effective therapy for nausea and vomiting of pregnancy:, a randomized, double-blind placebo controlled study. Obstetricsand Gynecology 1991;78: 33–36

    CAS  Google Scholar 

  41. Vutyavanich T, Wongtra-ngan S, Ruangsri R. Pyridoxine for nausea and vomit ing of pregnancy, a randomized, double-blind, placebo controlled trial. American Journal of Obstetricsand Gynecology 1995;173: 881–884

    Article  CAS  Google Scholar 

  42. Ellis JM, Kishi T, Azuma J, Folkers K. Vitamin — deficiency in patients with a c1inical syndrome including the carpal tunnel defect. Biochemical and c1inical response to therapy with pyridoxine. Research Communications in Chemical Pathology and Pharmacology 1976; 13: 743–757

    CAS  Google Scholar 

  43. Ellis JM, Folkers K. Clinical aspects of treatment of carpal tunnel syndrome with vitamin B6. Annals of the New York Academy of Seiences 1990;585: 302–320

    Article  CAS  Google Scholar 

  44. Amadio Pe. Carpal tunnel syndrome, pyridoxine, and the work place. Journal of the Hand Surgeons of America 1978; 12:875–880

    Google Scholar 

  45. Stransky M, Rubin A, Lava NS, Lazaro RP. Treatment of carpal tunnel syndrome with vitamin B6: a double blind study. Southern Medical Journal 1989; 82: 841–842

    Article  CAS  Google Scholar 

  46. Dakshinamurti K, LaI KJ. Vitamins and hypertension. World Review of Nutrition and Dietetics 1992;69: 40–73

    CAS  Google Scholar 

  47. Dakshinamurti K, LeBlanq WD, HerchI R, Havelicek V. Non-parallel changes in brain monoamines of pyridoxal deficient growing rats. Experimental Brain Research 1976; 26: 355–366

    Article  CAS  Google Scholar 

  48. Paulose CS, Dakshinamurti K, Packer S, Stephens NL. Sympathetic stimulation and hypertension in the pyridoxine deficient adult rat. Hypertension 1998;11: 387–391

    Article  Google Scholar 

  49. Lai KJ, Dakshinamurti K. The relationship between low calcium induced increase in systolic blood pressure and vitamin B6. Journal of Hypertension 1995; 13: 327–332

    Google Scholar 

  50. Fregly MJ, Cade JR. Effect of pyridoxine and tryptophan, alone and combined, on the development of deoxycorticosterone acetate induced hypertension in rats. Pharmacology 1995;50:298–306

    Article  CAS  Google Scholar 

  51. Lai KJ, Dakshinamurti K, Thliveris J. The effect of vitamin B6 on the systolic blood pressure of rats in various animal models of hypertension. Journal of Hypertension 1996; 14: 355–363

    Article  Google Scholar 

  52. Aybak M, Sermet A, Ayyildiz MO, Karakilcik AZ. Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension. Arzneimittelforschung 1995; 45: 1271–1273

    CAS  Google Scholar 

  53. Vilter RW. The vitamin B6-hydrazide relationship. Vitamins and Hormones 1964; 22: 797–805

    Article  CAS  Google Scholar 

  54. Snider DE. Pyridoxine supplementation during isoniazid therapy. Tubercle 1980; 61: 191–196

    Article  Google Scholar 

  55. Bender DA, Russell Iones R. Isoniazid-induced pellagra despite vitarnin-B6, supplernentation. Lancet 1979;(ii), 1125–1126

    Article  Google Scholar 

  56. Bender DA, Earl CJ, Lees AJ. Niacin depletion in Parkinsonian patients treated with L-dopa, benserazide and carbidopa. Clinical Science 1979; 56: 89–93

    CAS  Google Scholar 

  57. Fellman JH, Roth ES. Inh ibition of tyrosine aminotransferase activity by L-dihydroxyphenylalanine. Biochemistry 1971; 10: 408–414

    Article  CAS  Google Scholar 

  58. Glenn GM, Krober MS, Kelly P, McCarty J, Weir M. Pyridoxine as therapy in theophylline induced seizures. Veterinary and Human Toxicology 1995; 37: 342–345

    CAS  Google Scholar 

  59. Hansson O, Sillanppaa M. Pyridoxine and serum concentration of phenytoin and phenobarbitone. Lancet 1976;(i) 256

    Article  Google Scholar 

  60. Phillips WE, Mills JH, Charbonneau SM, Tryphonas L, Hatina GV, Zawidzka Z, Bryce FR, MunroIe. Subacute toxicity of pyridoxine hydrochloride in the beagle dog. Toxicology and Applied Pharmacology 1978;44: 323–333

    Article  CAS  Google Scholar 

  61. Krinke G, Schaumburg HH, Spencer PS, Suter J, Thomann O, Hess R. Pyridoxine megavitaminosis produces degeneration of peripheral sensory neurons (sensory neuronopathy) in the dog. Neurotoxicology 1980;2: 13–24

    Google Scholar 

  62. Schaeppi U, Krinke G. Pyridoxine neuropathy: correlation of functional tests and neuropathology in beagle dogs treated with large doses of vitamin B6. Agentsand Aetions 1982; 12:575–582

    Article  CAS  Google Scholar 

  63. Schaumburg H, Kaplan J, Windebank A, Vick N, Rasmus S, Pleasure D, Brown MJ. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. New England Journal of Medicine 1983;309: 445–448

    Article  CAS  Google Scholar 

  64. McLachlan RS, Brown WE Pyridoxine dependent epilepsy with iatrogenic sensory neuronopathy. Canadianjournal of Neurological Science 1995; 22: 50–51

    CAS  Google Scholar 

  65. Mpofu C, Alani SM, Whitehouse C, Fowler B, Wraith JE. No sensory neuropathy during pyridoxine treatment in homocystinuria. Archives of Disease in Childhood 1991; 66: 1081–1082

    Article  CAS  Google Scholar 

  66. Dalton K, Dalton MJ. Characteristics of pyridoxine overdose neuropathy syndrome. Acta Neurologica Scandinavica 1987;76: 8–11

    Article  CAS  Google Scholar 

  67. On-Line Mendelian Inheritance in man http://www3.ncbi.nlm.nih.gov/Omim/

    Google Scholar 

Download references

Authors
  1. David A. Bender
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Public Health Nutrition Unit Trinity and All Saints, College of the University of Leeds, Leeds, LS18 5HD, UK

    Joan K. Ransley  & Judith K. Donnelly  & 

  2. The Centre for Integrated Medicine Institute for General Practice and Primary Care, University of Sheffield Northern General Hospital, Sheffield, S5 7AU, UK

    Nicholas W. Read

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bender, D.A. (2001). Nutritional and Non-Nutritional Uses of Vitamin B6 . In: Ransley, J.K., Donnelly, J.K., Read, N.W. (eds) Food and Nutritional Supplements. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56623-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56623-3_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62598-5

  • Online ISBN: 978-3-642-56623-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation